384 related articles for article (PubMed ID: 15168774)
21. MicroRNAs and Adrenocortical Tumors: Where do we Stand on Primary Aldosteronism?
Tömböl Z; Turai PI; Decmann Á; Igaz P
Horm Metab Res; 2020 Jun; 52(6):394-403. PubMed ID: 32168526
[TBL] [Abstract][Full Text] [Related]
22. A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma.
Sato M; Miyauchi A; Namihira H; Bhuiyan MM; Imachi H; Murao K; Takahara J
Endocrine; 2000 Jun; 12(3):223-6. PubMed ID: 10963041
[TBL] [Abstract][Full Text] [Related]
23. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
[TBL] [Abstract][Full Text] [Related]
24. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
25. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
[TBL] [Abstract][Full Text] [Related]
26. Primary aldosteronism and hypercortisolism due to bilateral functioning adrenocortical adenomas.
Oki K; Yamane K; Sakashita Y; Kamei N; Watanabe H; Toyota N; Shigeta M; Sasano H; Kohno N
Clin Exp Nephrol; 2008 Oct; 12(5):382-387. PubMed ID: 18543063
[TBL] [Abstract][Full Text] [Related]
27. A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.
Cho YY; Chung YJ
Medicine (Baltimore); 2021 Jun; 100(25):e26382. PubMed ID: 34160414
[TBL] [Abstract][Full Text] [Related]
28. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.
Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N
Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646
[TBL] [Abstract][Full Text] [Related]
29. Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.
Kjellman M; Roshani L; Teh BT; Kallioniemi OP; Höög A; Gray S; Farnebo LO; Holst M; Bäckdahl M; Larsson C
J Clin Endocrinol Metab; 1999 Feb; 84(2):730-5. PubMed ID: 10022445
[TBL] [Abstract][Full Text] [Related]
30. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
[TBL] [Abstract][Full Text] [Related]
31. Polymorphic variation of CYP11B2 predicts postoperative resolution of hypertension in patients undergoing adrenalectomy for aldosterone-producing adenomas.
Wang W; Hu WL; Zhang LC; Xiao YS; Liu J; Bin C
Int J Urol; 2012 Sep; 19(9):813-20. PubMed ID: 22650983
[TBL] [Abstract][Full Text] [Related]
32. Somatic mutation of the MEN1 gene in parathyroid tumours.
Heppner C; Kester MB; Agarwal SK; Debelenko LV; Emmert-Buck MR; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Kim YS; Saggar SK; Lubensky IA; Zhuang Z; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
[TBL] [Abstract][Full Text] [Related]
33. Primary aldosteronism with concurrent primary hyperparathyroidism in a patient with arrhythmic disorders.
Petramala L; Savoriti C; Zinnamosca L; Marinelli C; Settevendemmie A; Calvieri C; Catani M; Letizia C
Intern Med; 2013; 52(18):2071-5. PubMed ID: 24042515
[TBL] [Abstract][Full Text] [Related]
34. Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
Bräutigam K; Nesti C; Riss P; Scheuba C; Niederle B; Grob T; Di Domenico A; Neuenschwander M; Mazal P; Köhn N; Trepp R; Perren A; Kaderli RM
Virchows Arch; 2024 May; 484(5):789-798. PubMed ID: 38244045
[TBL] [Abstract][Full Text] [Related]
35. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
[TBL] [Abstract][Full Text] [Related]
36. [Case of Cushing's syndrome caused by adrenal adenoma complicated with primary hyperparathyroidism due to parathyroid adenoma].
Ohara N; Takasu N; Komiya I; Takeda S; Otsuka H; Yamauchi K; Hiramatsu K; Yamada T; Hashizume K; Tokuda T
Nihon Naika Gakkai Zasshi; 1993 Oct; 82(10):1715-7. PubMed ID: 7901294
[No Abstract] [Full Text] [Related]
37. [Primary aldosteronism: new insights into familial forms].
van den Meiracker AH; van der Linde AA; Claahsen van der Grinten HL; Danser AH; Deinum J
Ned Tijdschr Geneeskd; 2015; 159():A8932. PubMed ID: 26420144
[TBL] [Abstract][Full Text] [Related]
38. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
39. Putative parathyroid tumor suppressor on 1p: independent molecular mechanisms of tumorigenesis from 11q allelic loss.
Imanishi Y; Tahara H
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S165-7. PubMed ID: 11576946
[TBL] [Abstract][Full Text] [Related]
40. Two novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.
Ozturk M; Chiu CY; Akdeniz N; Jenq SF; Chang SC; Hsa CY; Jap TS
J Endocrinol Invest; 2006 Jun; 29(6):523-7. PubMed ID: 16840830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
